Skip to Content
Merck
  • Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.

Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.

Journal of the American Society for Mass Spectrometry (2010-06-29)
Eric Martineau, Janna M de Guzman, Lioudmila Rodionova, Xianqi Kong, Paul M Mayer, Ahmed M Aman
ABSTRACT

This paper describes an efficient and reproducible screening method for identifying low molecular weight compounds that bind to amyloid beta peptides (Abeta) peptides using electrospray ionization mass spectrometry (ESI-MS). Low molecular weight compounds capable of interacting with soluble Abeta may be able to modulate/inhibit the Abeta aggregation process and serve as potential disease-modifying agents for AD. The present approach was used to rank the binding affinity of a library of compounds to Abeta1-40 peptide. The results obtained show that low molecular weight compounds bind similarly to Abeta1-42, Abeta1-40, as well as Abeta1-28 peptides and they underline the critical role of Abeta peptide charge motif in binding at physiological pH. Finally, some elements of structure-activity relationship (SAR) involved in the binding affinity of homotaurine to soluble Abeta peptides are discussed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3-Amino-1-propanesulfonic acid, 97%